1. Bastert J., Schaller M., Korting H.C., Evans E.G.V.: Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.Internat.J.Antimicrob.Agents 17, 81–91 (2001).
2. Kubicová L., Waisser K.: Biological activity of salicylanilides. (In Czech)Českosl.Farm. 41, 208–216 (1992).
3. Macielag M.J., Demers J.P., Fraga-Spano S.A., Hlasta D.J., Johnson S.G., Kanojia R.M., Russell R.K., Sui Z., Weidner-Wells M.A., Werblood H., Foleno B.D., Goldschmidt R.M., Loeloff M.J., Webb G.C., Barrett J.F.: Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.J.Med.Chem. 41, 2939–2945 (1998).
4. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard.Document M27-A. National Committee for Clinical Laboratory Standards, Wayne (PA) 1997.
5. National Committee For Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard.Document M38-P. National Committee for Clinical Laboratory Standards, Wayne (PA) 1997.